• HyperScribe T7 High Yield RNA Synthesis Kit Workflows

  2026-09-26

  Build RNA transcripts for programmable, hairpin-driven protein granule experiments, with practical controls to distinguish RNA concentration effects from sequence design. The workflow pairs T7 transcription with fit-for-purpose labeling and cleanup while keeping yield expectations and optimization steps grounded in the kit specifications.

• URB597 and Pain: Testing FAAH-Dependent Mechanisms

  2026-09-25

  URB597 (KDS-4103) offers a selective way to test how FAAH-dependent endocannabinoid signaling contributes to inflammatory pain. This article interprets recent cannabidiol findings as a framework for separating sensory, affective, peripheral, and central mechanisms—not as evidence that the two compounds act identically.

• HyperScribe T7 High Yield RNA Synthesis Kit in IDD

  2026-09-25

  Connect findings on the ROS–ferroptosis–inflammation cycle in intervertebral disc degeneration with practical RNA assay design. The HyperScribe™ T7 High Yield RNA Synthesis Kit supports research workflows from RNA probes and antisense transcripts to capped or modified RNA, with a reported yield of up to approximately 50 μg per standard reaction.

• Tioconazole: Mechanism and Research Use

  2026-09-24

  Tioconazole is an antifungal medication whose azole-class mechanism disrupts fungal ergosterol production. This research-use product page explains the compound’s reported properties, practical handling boundaries, and the evidence researchers should verify before interpreting an assay.

• DRB: Separating Transcription from Translation

  2026-09-24

  5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) can help researchers probe how transcriptional disruption relates to downstream RNA and protein output. This article connects DRB’s pharmacology to recent work on lncRNA-mediated translation while clarifying what the comparison can—and cannot—show.

• Trichostatin A (TSA) in Breast Cancer Assays

  2026-09-23

  Use Trichostatin A to probe histone deacetylase activity, chromatin responses, and growth phenotypes in breast cancer models. A receptor-aware workflow helps separate TSA’s epigenetic effects from the distinct CHK1 responses reported across ER/PR-defined tumors.

• MK-571 (L-660,711) Workflow Guide

  2026-09-23

  Build cleaner airway-inflammation and transporter experiments with MK-571 (L-660,711), using receptor-focused controls alongside MRP1-aware assay design. This guide translates its DMSO handling, leukotriene pharmacology, and transporter relevance into practical workflows for asthma research and leukotriene-mediated inflammation research.

• Okadaic acid (A4540): PP1/PP2A Workflow

  2026-09-22

  Okadaic acid (A4540) provides concentration-dependent inhibition of PP2A and PP1 for phosphorylation-signaling and apoptosis workflows. This guide explains practical assay setup, controls, and interpretation limits; it should not be treated as a universal phosphatase inhibitor or as a validated protocol for an untested model.

• HyperScribe™ Poly (A) Tailing Kit for Assay Control

  2026-09-22

  The HyperScribe™ Poly (A) Tailing Kit enables controlled enzymatic RNA polyadenylation for stronger assay design, not merely improved transcript handling. This article connects poly(A)-tail standardization with mechanistic studies of RNA-driven protein expression and the TCAIM–OGDH metabolic axis.

• Cabozantinib (XL184) in RCC Research

  2026-09-21

  Build acute-versus-chronic renal cell carcinoma workflows with Cabozantinib (XL184), linking RTK suppression to phosphoproteomic, migration, invasion, and angiogenesis readouts. Practical formulation, assay, and troubleshooting guidance helps distinguish immediate cytostatic effects from chronic adhesion- and stress-associated adaptation.

• 2,7-Dichlorodihydrofluorescein diacetate ROS Workflows

  2026-09-21

  Build more reliable intracellular ROS measurements with DCFH-DA across microscopy, flow cytometry, and plate-based formats. This guide connects rapid redox phenotyping with the reference study’s genome-wide analysis of Arabidopsis plastid DNA breaks while clearly separating oxidative-stress signals from direct DNA-damage evidence.

• 2X Taq PCR Master Mix (with dye): Lab Guide

  2026-09-20

  This scenario-driven guide explains how SKU K1034, the 2X Taq PCR Master Mix (with dye), can support molecular quality control around cell viability, proliferation, and cytotoxicity studies. It links practical PCR design, endpoint interpretation, vendor selection, and infectious-disease research context while clearly defining the reagent’s technical limits.

• PEI-Laminarin Nanoparticles as OVA Vaccine Adjuvant

  2026-09-19

  The reference study developed polyethyleneimine-modified laminarin nanoparticles that combine cationic antigen loading with polysaccharide-mediated immune stimulation. In an ovalbumin model, the formulation improved dendritic-cell uptake, maturation, lysosomal escape, antigen cross-presentation, and both humoral and cellular immune responses relative to aluminum adjuvant.

• BIRC2/BIRC3 Regulation in Pulmonary Epithelium

  2026-09-18

  The reference study distinguishes how inflammatory cytokines and glucocorticoids regulate the inhibitor-of-apoptosis genes BIRC2 and BIRC3 in pulmonary epithelial models. Its comparative use of epithelial cell lines and primary bronchial cells shows that BIRC3 is highly inducible and context-sensitive, whereas BIRC2 is comparatively constitutive, clarifying how these related proteins may support inflammatory signaling and epithelial survival.

• Azithromycin Beyond Bacteria: Assay Design

  2026-09-18

  Azithromycin is more than a macrolide antibiotic model: it can connect ribosome-focused bacterial infection research with senolytic assay design. This guide explains how to separate antimicrobial activity, host-cell toxicity, senolysis, and trypanocidal observations in reproducible workflows.

548 records 3/37 page Previous Next 12345 下5页 Last page